Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Explore budgeting tips that drive financial success through precise allocations, goal alignment, and disciplined spending controls.
22,313 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
A widening Epstein-related inquiry fuels renewed scrutiny of global power players. As whispers of the former Prince A...
A quiet, repeating four-year rhythm has intrigued investors for decades. This article explains what the stock market ...
Investors brace for a potential 2026 stock market crash as volatility rises. Three defensive ETFs offer ballast with ...
As CEO succession races tighten, boards are increasingly offering multimillion-dollar packages to second-place conten...
A new DeFi bill in Congress could reshape who bears liability and how crypto markets are organized. This article brea...
A veteran diplomat weighs the odds of regime change in Iran as U.S.-led strikes escalate, warning that history in the...
Connecticut lawmakers introduced Senate Bill 340 to require public marketing of most 1-4 unit residential listings, w...
Global brain health costs total $5 trillion annually, with forecasts for $16 trillion by 2030. The crisis is reshapin...
NVIDIA backs LUMENTUM and COHERENT with a $4B stake to accelerate AI data movement; analysts weigh the upside and ris...
Tensions in the Strait of Hormuz have intensified, with ships stalled and crude prices rising. The ripple effects tou...
Celebrity-backed meme coins surge on hype and fade on reality. This deep dive explains why the Trump meme coin down t...